Team: Executive Committee

Home » Our Mission » Who We Are » Staff »
Berra Yazar-Klosinski, Ph.D.
Berra Yazar-Klosinski, Ph.D.

Berra Yazar-Klosinski, Ph.D.

Chief Scientific Officer

Berra Yazar-Klosinski, Ph.D., the chief scientific officer of MAPS Public Benefit Corporation (MAPS PBC), is responsible for regulatory affairs, pharmacovigilance, medical affairs, pharmacology and toxicology.Shebegan working on the clinical development of MDMA-assisted therapy when she joined MAPS in 2009 and has been with MAPS PBC since its inception in 2014. Over the years Berra has supported the various stages of clinical development and regulatory affairs, while authoring numerous publications on MDMA-assisted therapy, LSD-assisted psychotherapy, cannabis, and ibogaine. She has developed a strong track record of success with FDA, EMA and other regulatory agencies. Prior to MAPS PBC, Berra gained clinical research experience working in laboratories at Geron Corporation and Millennium Pharmaceuticals. She earned her B.S. in Biology with a minor in Drama from Stanford University and her Ph.D. in Molecular, Cell, and Developmental Biology from the University of California, Santa Cruz.

MAPS Public Benefit Corporation

Our Mission
Who We Are
Careers
News
FAQ
Contact Us
Privacy Policy

3141 Stevens Creek Blvd #40547
San Jose, CA 95117

MAPS PBC is a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS). MAPS is a 501(c)(3) non-profit research and educational organization.

Stay Up-to-Date about the MDMA-AT Education Program

You have Successfully Subscribed!